Cutler Group LP Ascendis Pharma A/S Put Options Transaction History

Cutler Group LP

15 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 Apr 19, 2024	BUY	$123.45 - $159.4 $370,350 - $478,200	3,000 New	3,000 $7,000
Q3 2022 Oct 25, 2022	BUY	$84.03 - $110.23 $252,090 - $330,690	3,000 New	3,000 $4,000
Q1 2022 Apr 14, 2022	BUY	$102.18 - $135.75 $592,644 - $787,350	5,800 New	5,800 $4,000
Q4 2021 Jan 18, 2022	SELL	$127.1 - $169.66 $114,390 - $152,694	-900 Closed	0 $0
Q3 2021 Oct 26, 2021	BUY	$112.67 - $176.92 $101,403 - $159,228	900 New	900 $5,000
Q2 2021 Jul 19, 2021	SELL	$121.62 - $145.29 $364,860 - $435,870	-3,000 Closed	0 $0
Q4 2020 Jan 21, 2021	BUY	$151.2 - $182.76 $151,200 - $182,760	1,000 Added 50.0%	3,000 $2,000
Q2 2020 Jul 22, 2020	SELL	$110.87 - $156.01 $354,784 - $499,232	-3,200 Reduced 61.54%	2,000 $3,000
Q1 2020 May 07, 2020	BUY	$97.01 - $145.11 $485,050 - $725,550	5,000 Added 2500.0%	5,200 $80,000
Q4 2019 Feb 06, 2020	SELL	$91.45 - $139.12 $923,645 - $1.41 Million	-10,100 Reduced 98.06%	200 $0
Q2 2019 Aug 09, 2019	SELL	$107.11 - $132.09 $1.19 Million - $1.47 Million	-11,100 Reduced 51.87%	10,300 $5,000
Q1 2019 May 10, 2019	BUY	$62.15 - $129.99 $652,575 - $1.36 Million	10,500 Added 96.33%	21,400 $37,000
Q4 2018 Feb 05, 2019	BUY	$55.16 - $69.67 $187,544 - $236,878	3,400 Added 45.33%	10,900 $71,000
Q3 2018 Nov 07, 2018	BUY	$63.77 - $76.28 $318,850 - $381,400	5,000 Added 200.0%	7,500 $40,000
Q2 2018 Aug 10, 2018	BUY	$58.55 - $73.92 $146,375 - $184,800	2,500 New	2,500 $12,000

244

58.8M

250K

377K

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.75B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.